NEPHRAEGIS THERAPEUTICS

nephraegis-therapeutics-logo

Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).

#SimilarOrganizations #People #Financial #Website #More

NEPHRAEGIS THERAPEUTICS

Industry:
Biopharma Biotechnology Health Care Medical Therapeutics

Founded:
2018-01-01

Address:
Lake Forest, Illinois, United States

Country:
United States

Website Url:
http://www.nephraegis.com

Status:
Active

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Organization Schema Typekit LocalBusiness Schema Squarespace


Similar Organizations

anthos-therapeutics-logo

Anthos Therapeutics

Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.

ceptaris-therapeutics-logo

Ceptaris Therapeutics

Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.


Current Advisors List

ben-askew_image

Ben Askew Board Member @ Nephraegis Therapeutics
Board_member

chris-garabedian_image

Chris Garabedian Board Member @ Nephraegis Therapeutics
Board_member

jim-stolzenbach_image

Jim Stolzenbach Board Member @ Nephraegis Therapeutics
Board_member

bryan-f-cox_image

Bryan F. Cox Board Member @ Nephraegis Therapeutics
Board_member

richard-marshak_image

Richard Marshak Board Member @ Nephraegis Therapeutics
Board_member

Current Employees Featured

bryan-f-cox_image

Bryan F. Cox
Bryan F. Cox Chief Executive Officer @ Nephraegis Therapeutics
Chief Executive Officer

jim-stolzenbach_image

Jim Stolzenbach
Jim Stolzenbach Chief Development Officer @ Nephraegis Therapeutics
Chief Development Officer

richard-marshak_image

Richard Marshak
Richard Marshak Chief Business Officer @ Nephraegis Therapeutics
Chief Business Officer

Investors List

xontogeny_image

Xontogeny

Xontogeny investment in Seed Round - Nephraegis Therapeutics

Official Site Inspections

http://www.nephraegis.com

  • Host name: 198.185.159.144
  • IP address: 198.185.159.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Nephraegis Therapeutics" on Search Engine